Florence Lerebours

机构：Hôpital René Huguenin, Institut Curie · ORCID：0009-0006-1895-4269

发表论文 64 篇 · 总被引 248 次 · h-index 6

代表论文

• Darolutamide or capecitabine in triple-negative, androgen receptor-positive, advanced breast cancer (UCBG 3-06 START): a multicentre, non-comparative, randomised, phase 2 trial (2025 · The Lancet Oncology · 被引 24)
• Cognition and Return to Work Status 2 Years After Breast Cancer Diagnosis (2024 · JAMA Network Open · 被引 21)
• HER2CLIMB-05: A Phase III Study of Tucatinib Versus Placebo in Combination With Trastuzumab and Pertuzumab as First-Line Maintenance Therapy for HER2+ Metastatic Breast Cancer (2025 · Journal of Clinical Oncology · 被引 10)
• Treatment toxicities and pathological response through the evolution of neoadjuvant regimens in early triple-negative breast cancer (2025 · ESMO Real World Data and Digital Oncology · 被引 3)
• Interaction between APOE Ɛ4 status, chemotherapy and endocrine therapy on cognitive functioning among breast cancer survivors: the CANTO-Cog longitudinal study (2025 · Breast Cancer Research · 被引 3)
• Working conditions associated with return to work 2 years after breast cancer: insights from a cohort study (2025 · British Journal of Cancer · 被引 2)